Oncological and aesthetic considerations of skin-sparing mastectomy
Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women
αB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer
NF-κB pathway inhibitors preferentially inhibit breast cancer stem-like cells
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients
JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer
A polymorphism in the G protein β3-subunit gene is associated with bone metastasis risk in breast cancer patients
Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptorβ in primary invasive breast carcinomas
Midregion PTHrP regulates Rip1 and caspase expression in MDA-MB231 breast cancer cells
High frequency of HIF-1α overexpression in BRCA1 related breast cancer
A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk
Surveillance mammography and the risk of death among elderly breast cancer patients
MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish–Ashkenazi descent
BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer
Tumor-derived CCL5 does not contribute to breast cancer progression
Brain metastases in breast cancer : Prognostic factors and management
Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast
A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma
Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case–control study
Differences in breast cancer biological characteristics between ethnic groups in New Zealand
Population attributable risks for breast cancer in Swedish women by morphological type
ERCC1 expression in triple negative breast carcinoma : The paradox revisited